The End of the Semaglutide Shortage
The U. S. Food and Drug Administration (FDA) has announced that the long-standing shortage of semaglutide, the active ingredient in Novo Nordisk's weight loss injection Wegovy and diabetes treatment Ozempic, has finally been resolved. This decision comes after more than two years of scarcity, which